beeldscherm schreef op 4 oktober 2017 10:03:
Breaking the Million Dollar Barrier
People with $1 million or more in annual pharmacy spend are no longer one in a million: the number of Americans reaching that amount, while rare, doubled between 2014 and 2016.
Hereditary angioedema (HAE), a rare disorder characterized by recurrent and often life-threatening episodes of severe swelling, was the leading indication for treatment for people with $1 million in annual pharmacy costs in 2016, followed by enzyme deficiency disorders and hemophilia. There are only six approved therapies to treat the approximately 6,500 people in the U.S. who have HAE, with the cost ranging from $12,000 to $2 million per treatment. Prior to the discovery of these medications, one-third of people with HAE died of asphyxiation due to swelling in their airways.
ook in de US exploderen de Zorgkosten,en diegene die zijn prijs v/h medicijn tegen HAE kan verlagen is/word spekkoper...denk dat Pharming bij de 2 goedkoopste zit